Table 2.
Application of sequentially rejective multiple test procedure
| Variables | Raw p-value | i | Adj. p-value |
|---|---|---|---|
| Diagnosis age | 0.0281 | 11 | 0.3372 |
| Gender | 0.0019 | 8 | 0.0285 |
| Smoking habit | 0.0001 | 1 | 0.0022 |
| Immunosuppressive therapy | 0.0002 | 2 | 0.0042 |
| Duration of immunosuppr. Therapy | 0.0032 | 9 | 0.0448 |
| Biological drugs | 0.0004 | 4 | 0.0076 |
| Duration of biological treatment | 0.0053 | 10 | 0.0689 |
| Re-hospitalization | 0.0008 | 7 | 0.0128 |
| Adverse events | 0.0007 | 6 | 0.0119 |
| Infections | 0.6274 | 18 | 0.9999 |
| Cancers | 0.2755 | 15 | 0.9999 |
| Diabetes | 0.0006 | 5 | 0.0108 |
| Hypertension | 0.7376 | 20 | 0.9999 |
| Heart failure | 0.9852 | 22 | 0.9999 |
| Kidney failure | 0.5074 | 16 | 0.9999 |
| Pulmonary failure | 0.1553 | 14 | 0.9999 |
| Neuropathy | 0.8858 | 21 | 0.9999 |
| Liver disease | 0.6075 | 17 | 0.9999 |
| Charlson score | 0.0316 | 12 | 0.3476 |
| Surgery | 0.0003 | 3 | 0.0060 |
| Final exitus | 0.6643 | 19 | 0.9999 |
| Follow-up time | 0.0567 | 13 | 0.5770 |